Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 1234 Impact of infections in p...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
1234 Impact of infections in patients receiving immune checkpoint inhibitor therapies for non-small cell lung cancer (NSCLC)

1234 Impact of infections in patients receiving immune checkpoint inhibitor therapies for non-small cell lung cancer (NSCLC)

Bibliographic Details
Main Authors: Jun Zhang, Kai Sun, Maen Abdelrahim, Zimu Gong, Yuqi Zhang, Catherine Wiechmann, Jiaqiong Xu, Ethan Burns, Ryan Kieser, Ibrahim Muhsen, Shivan Shah, Godsfavour Umoru, Aubrey Crenshaw, Abdullah Esmail, Kelly Gee, Monisha Singh, Eric Bernicker
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • 1233 Impact of infections occurring in patients receiving immune checkpoint inhibitors for renal cell carcinoma (RCC)
    by: Jun Zhang, et al.
    Published: (2023-11-01)
  • 451 Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving Atezolizumab
    by: Kai Sun, et al.
    Published: (2023-11-01)
  • Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer
    by: Emaan Haque, et al.
    Published: (2022-12-01)
  • Hyperprogressive NSCLC With Two Immune-Checkpoint Inhibitors
    by: Saro Kasparian, MD, et al.
    Published: (2020-06-01)
  • Incidence and outcome of immune checkpoint-induced pneumonitis in oncology patients with history of pulmonary disease
    by: Emily Allen, et al.
    Published: (2023-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs